• Grifols SA GRFS.OQ reported quarterly adjusted earnings of 20 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 15 cents. The lone analyst forecast for the quarter was for earnings of 20 cents per share.

• Revenue rose 4% to €1.89 billion from a year ago; analysts expected €1.86 billion.

• Grifols SA's reported EPS for the quarter was 17 cents​.

• The company reported quarterly net income of €117.06 million.

• Grifols SA shares had risen by 11.6% this quarter and gained 35.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.1% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Grifols SA is $11.50, about 12.3% above its last closing price of $10.09

This summary was machine generated from LSEG data July 29 at 05:53 p.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)